` GENT (Gentian Diagnostics ASA) vs Oslo OBX Comparison - Alpha Spread

GENT
vs
Oslo OBX

Over the past 12 months, GENT has underperformed Oslo OBX, delivering a return of 0% compared to the Oslo OBX's 16% growth.

Stocks Performance
GENT vs Oslo OBX

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
GENT vs Oslo OBX

Loading
GENT
Oslo OBX
Difference

Performance By Year
GENT vs Oslo OBX

Loading
GENT
Oslo OBX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Gentian Diagnostics ASA vs Peers

Oslo OBX
GENT
7741
ALC
COLO B
ALGN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Gentian Diagnostics ASA
Glance View

Market Cap
626.1m NOK
Industry
Health Care

Gentian Diagnostics ASA is a medical diagnostics company. The company is headquartered in Moss, Ostfold. The company went IPO on 2016-12-14. The firm develops and manufactures in vitro diagnostic (IVD) products for the detection and quantification of specific markers for use on a wide range of clinical chemistry analysers. The Company’s product portfolio comprises turbidimetric fecal calprotectin immunoassay, which is to be run on clinical chemistry analysers: The Gentian Calprotectin Immunoassay, Cystatin C, NT-proBNP - Pre-launch, SARS-CoV-2 Ab Pre-Launch, Canine CRP and Beckman Coulter Customers. The firm is based in Moss, Norway, serving the global human and veterinary diagnostics markets through sales and representative offices in Sweden, USA and China.

GENT Intrinsic Value
34.19 NOK
Overvaluation 16%
Intrinsic Value
Price
G
Back to Top